about
Adult neurogenesis in the mammalian brain: significant answers and significant questionsEphBs: an integral link between synaptic function and synaptopathiesNeural stem cell niches in health and diseasesMelanoma: from mutations to medicineGene Expression Profiling of Muscle Stem Cells Identifies Novel Regulators of Postnatal Myogenesis.A mathematical model for eph/ephrin-directed segregation of intermingled cellsSystemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcomaComplex formation of EphB1/Nck/Caskin1 leads to tyrosine phosphorylation and structural changes of the Caskin1 SH3 domainSlit/Robo signaling modulates the proliferation of central nervous system progenitorsSinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear.Promiscuous and specific recognition among ephrins and Eph receptorsPeritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinomaA comprehensive map of the human urinary proteomeEvidence that the EphA2 receptor exacerbates ischemic brain injury.In PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I.EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.Genomic aberrations in young and elderly breast cancer patients.Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell CarcinomaEph receptor and ephrin function in breast, gut, and skin epithelia.Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.The multifaceted roles of Eph/ephrin signaling in breast cancer.A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development.Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.Intronic cleavage and polyadenylation regulates gene expression during DNA damage response through U1 snRNAEph receptor signaling and ephrinsCancer stem cells as a potential therapeutic target in thyroid carcinoma.The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer.Targeting Eph receptors with peptides and small molecules: progress and challenges.Eph-dependent cell-cell adhesion and segregation in development and cancer.EPHA3 as a novel therapeutic target in the hematological malignancies.The role of EPH receptors in cancer-related epithelial-mesenchymal transitionTherapeutic targeting of EPH receptors and their ligands.Eph receptors and ephrins: therapeutic opportunities.The role of Eph receptors and Ephrins in the skin.EphA4 receptor is a novel negative regulator of osteoclast activity.Ephrin-B stimulation of calvarial bone formation.
P2860
Q24628935-D597FDBC-CB5C-474E-A370-589E49B26386Q26863347-68C09CBA-0970-48A0-8B7D-931EF4176CD7Q26995185-C146E537-F042-430F-B434-70687522CEB5Q27024061-F17AE97F-468B-46C3-9A81-A5A876238E61Q27330466-E3BF43FF-8C00-48E5-8106-A8F21DF83CCDQ27332202-019547BA-72BD-4652-8B25-E95B3B3DAAEAQ28485467-6818CDB1-B550-403E-AD5F-BDB5C3D98B33Q30009972-E45F2EE1-B37F-4A70-8CD1-69CB046115B5Q30651695-7D352DD2-6BAD-462A-B75A-6D5B3FADB6F2Q30830186-232A3C69-41CE-469C-8BF3-91FCD48885A5Q33963081-D74AC587-5599-4653-B115-3B817F513ACCQ34150471-6535E8D6-3055-4907-A8BD-CDD1A96EF64FQ34364217-BF2A4CB3-F579-4906-B56E-77BCB0BC5CBDQ34424829-B3992522-DF47-4336-BB27-8F9AE70C16A6Q34545169-314CB191-1347-49D6-97EA-841194BB3332Q35040814-379727B4-73BD-4C90-A228-EB6420D065B6Q35210469-0FA5ADD8-255E-48F6-962D-D893279CEE10Q35801194-B39DD19E-3BF6-4D1B-85BB-9DF1AD9EF0BCQ35807554-8BC8C5B5-FEDD-4789-9F83-34618CE7BA6FQ35817738-39E9E7EB-E046-4AF6-BFE1-9156C2742A3AQ36125059-377F78E1-4121-4BF3-97C9-D143967C9F99Q36232264-FC0D8552-5435-4AFC-952E-EC5D2A48BCBAQ36402719-2DD2B2F5-7328-4090-AD53-B6DB96BEE22DQ36431270-A390B347-DBAE-4626-85D4-40674498FCBDQ36765650-B75B8135-5794-4442-9723-60A3084510A9Q36935007-61BE0B37-FF8E-4722-A26D-C5EDDAFA4145Q37001441-7BD70794-9BDF-4CCD-A4DD-3CCDB3A8643DQ37122330-1BF76C99-1C73-44AB-AE8B-987E07AF2ABFQ37288044-C8CF515C-8BF1-4E90-8079-C8B152FF0FBDQ37579565-89242B39-C4A5-41B3-BFC1-3D3D00650968Q37723106-00975B7B-1AB4-4DC4-8F45-F9008FAF160FQ37951723-9A9DB511-B7EE-41A3-A95B-2FC266045FE5Q37971902-062D3CCD-74E3-442E-B75F-FC05E1A19754Q38025161-77CAEB76-48FA-4F79-89C3-E88E74C91A12Q38150596-907C625C-5505-46C8-88F3-F10D73E7824DQ38174793-947A905D-E375-45A4-880B-C08EC6717C3EQ38257853-75D3A935-76C1-4417-A9BC-EB9F759CECC7Q38615784-5B989B94-CF11-46B9-818B-AB206304DB22Q39103942-749E6279-90F5-4C2E-9214-78E755CEDFAAQ39248946-D2784FA1-74EE-4C90-BE86-BCBE6C2A3CA4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Ephrins and Eph receptors in stem cells and cancer
@ast
Ephrins and Eph receptors in stem cells and cancer
@en
Ephrins and Eph receptors in stem cells and cancer
@nl
type
label
Ephrins and Eph receptors in stem cells and cancer
@ast
Ephrins and Eph receptors in stem cells and cancer
@en
Ephrins and Eph receptors in stem cells and cancer
@nl
prefLabel
Ephrins and Eph receptors in stem cells and cancer
@ast
Ephrins and Eph receptors in stem cells and cancer
@en
Ephrins and Eph receptors in stem cells and cancer
@nl
P3181
P1476
Ephrins and Eph receptors in stem cells and cancer
@en
P2093
Jonas Frisén
P304
P3181
P356
10.1016/J.CEB.2010.08.005
P407
P577
2010-10-01T00:00:00Z